Matt McNamara

Matt McNamara has a diverse work experience in various companies and roles. Matt is currently serving as the CIO and Director at Horizon 3 Healthcare since August 2020. Matt is also a Non Executive Director at Cardiac Dimensions, ESN Cleer Pty Ltd, Microbio, and Avecho Biotechnology Ltd, starting from 2023, 2020, 2020, and 2020 respectively. Previously, they worked as the Managing Director at Grey Innovation Investment Partners Pty Ltd from November 2019 to May 2023. Matt was a Non Executive Director at Adherium from October 2019 to February 2022. Matt also served as a Chief Investment Officer at Bioscience Managers Pty Ltd from December 2005 to December 2019. Additionally, they worked as a Non Executive Director at SeaDragon Marine Oils Limited from October 2012 to December 2019, and at Saluda Medical from February 2015 to November 2019.

Matt McNamara completed their education at three different institutions. Matt started their academic journey at Xavier College, although specific details about the degree and field of study are not available. Later, they attended La Trobe University from 1983 to 1986, earning a Bachelor of Science in Biochemistry Molecular Genetics. Finally, from 1992 to 1995, McNamara pursued their Master of Business Administration (MBA) with a focus on Commercialisation at the University of Sydney.